Login / Signup

Antibody and T-cell responses to SARS-CoV-2 vaccination in myeloproliferative neoplasm patients.

Joan HowKathleen M E GallagherYiwen LiuKatelin KatsisEva L ElderRebecca C LarsonMark B LeickDonna S NeubergMarcela V MausGabriela S Hobbs
Published in: Leukemia (2022)
Keyphrases
  • sars cov
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • low grade
  • patient reported outcomes
  • high grade